Vitamin B12 Supplementation for Burning Mouth Syndrome
Vitamin B12 supplementation is indicated for burning mouth syndrome (BMS) patients only when documented B12 deficiency is present, but not as routine treatment for all BMS patients. The evidence does not support universal B12 supplementation for BMS without confirmed deficiency.
Clinical Approach
Step 1: Screen for B12 Deficiency
- Measure serum B12 levels in all BMS patients, particularly those with:
- Neurological symptoms (sensory changes, motor symptoms, gait disturbances)
- Macrocytosis or anemia
- Risk factors: vegetarian/vegan diet, gastric surgery, metformin use, age >60 years, gastric parietal cell antibodies
- If B12 levels are indeterminate (low-normal), consider methylmalonic acid (MMA) testing to confirm true deficiency 1
Step 2: Treatment Based on Deficiency Status
If B12 Deficiency is Confirmed:
For patients with neurological involvement (including oral sensory symptoms):
- Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement
- Then maintenance: 1 mg IM every 2 months lifelong 2
- Seek urgent specialist advice from neurology and hematology 2
For patients without neurological involvement:
- Hydroxocobalamin 1 mg IM three times weekly for 2 weeks
- Then maintenance: 1 mg IM every 2-3 months lifelong 2
Alternative oral therapy (when malabsorption is not the cause):
- Oral cyanocobalamin 1000 μg daily 3
- Note: Oral absorption is unreliable in malabsorption conditions 4
If No B12 Deficiency is Present:
- Do not routinely supplement with B12 for BMS treatment
- The evidence for B12 in non-deficient BMS patients is very low quality 5
Evidence Quality and Nuances
The research evidence for B12 in BMS is conflicting and of very low quality. One study showed that BMS patients with confirmed B12 deficiency who received supplementation (as part of combination therapy with vitamin B complex and folic acid) experienced significant reduction in oral symptoms and homocysteine levels after 5.4-8.2 months 6. Another trial found benefit from vitamin B complex and zinc supplements in reducing pain/burning 7.
However, a comprehensive Cochrane review found insufficient evidence to support dietary supplements (including B vitamins) for BMS treatment, rating the evidence as very low quality 5. The positive studies did not isolate B12 as the sole intervention, making it impossible to attribute benefit specifically to B12.
Critical Caveats
Do not give folic acid before treating B12 deficiency - this can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord 2. Always check and treat B12 deficiency first.
BMS patients with gastric parietal cell antibodies have significantly higher rates of B12 deficiency (11.4% vs 3.8%), macrocytosis, anemia, and hyperhomocysteinemia compared to antibody-negative BMS patients 8. These patients warrant particularly careful screening.
Secondary BMS caused by B12 deficiency (presenting as atrophic glossitis with burning tongue) should be distinguished from primary BMS 9. Treatment of the underlying deficiency resolves secondary BMS, whereas primary BMS requires different management approaches 10.
The key is identifying true B12 deficiency through appropriate testing, then treating according to established deficiency protocols rather than empirically supplementing all BMS patients.